Neuroimaging Correlates of 22q11.2 Deletion Syndrome: Implications for Schizophrenia Research

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|12|21|2303-2313

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.12, Iss.21, 2012-11, pp. : 2303-2313

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Functional Biomarkers in Schizophrenia with Neuroimaging

By  

Current Pharmaceutical Design, Vol. 22, Iss. 14, 2016-04 ,pp. : 2117-2123

Bentham Science Publishers

Access to resources Recommend Favorite

Neuroimaging Correlates of Pharmacological and Psychological Treatments for Specific Phobia

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 6, 2014-08 ,pp. : 1021-1025

Bentham Science Publishers

Access to resources Recommend Favorite

Transcranial Magnetic Stimulation in Schizophrenia: The Contribution of Neuroimaging

By  

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 21, 2012-11 ,pp. : 2452-2457

Bentham Science Publishers

Access to resources Recommend Favorite

The Glutamate Hypothesis of Schizophrenia: Neuroimaging and Drug Development

By  

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 8, 2012-06 ,pp. : 1500-1512

Bentham Science Publishers

Access to resources Recommend Favorite

Neurochemistry of Schizophrenia: The Contribution of Neuroimaging Postmortem Pathology and Neurochemistry in Schizophrenia

By  

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 21, 2012-11 ,pp. : 2375-2392

Bentham Science Publishers

Access to resources Recommend Favorite